Cigna Using NCCN Content for Oncology Coverage Policy Development
As part of the company's coverage policy development, Cigna is using the NCCN Guidelines® and the NCCN Compendium® as references in the appropriate choice for the treatment of people with cancer in the United States. FORT WASHINGTON, PA - Cigna is using National Comprehensive Cancer Network® (NCCN®) Content as a resource for oncology coverage policy development and updates for the company's more than 840,000 providers throughout the United States. 'Cigna recognizes the important role that ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - October 2, 2014 Category: Cancer & Oncology Source Type: news

Patient-Friendly Guide Offers Free Step-by-Step Information for People with Soft Tissue Sarcoma
NCCN Guidelines for Patients®: Soft Tissue Sarcoma, available free-of-charge at NCCN.org/patients, is designed to provide people with cancer and their caregivers state-of-the-art treatment information in easy-to-understand language. FORT WASHINGTON, PA - People with various soft tissue sarcoma diagnoses need access to state-of-the-art treatment information in easy-to-understand language. The National Comprehensive Cancer Network® (NCCN®) has published the NCCN Guidelines for Patients®: Soft ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - September 18, 2014 Category: Cancer & Oncology Source Type: news

Poster Presentation Opportunity Available for Nation’s Top Researchers in Oncology
NCCN is accepting original abstracts from investigators for consideration for the NCCN 20th Annual Conference General Poster Session; Submissions will be accepted from NCCN Member Institutions, academic institutions, teaching and community hospitals, or industry. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) is now accepting original abstracts for consideration to be presented during the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ General Pos... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - September 14, 2014 Category: Cancer & Oncology Source Type: news

Poster Presentation Opportunity Available for Nation ’s Top Researchers in Oncology
NCCN is accepting original abstracts from investigators for consideration for the NCCN 20th Annual Conference General Poster Session; Submissions will be accepted from NCCN Member Institutions, academic institutions, teaching and community hospitals, or industry. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) is now accepting original abstracts for consideration to be presented during the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ General Pos... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - September 12, 2014 Category: Cancer & Oncology Source Type: news

Oncology Experts Mark 20 Years of Evidence-Based Decision-Making in Small Cell Lung Cancer
NCCN has published the 20th annual edition of its NCCN Guidelines® for Small Cell Lung Cancer, marking the first 20th edition of the eight original NCCN Guidelines published in November 1996. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) has published its 20th annual edition of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Small Cell Lung Cancer (SCLC). One of the eight original NCCN Guidelines®, the NCCN Guidelines for SCLC was initially ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - September 6, 2014 Category: Cancer & Oncology Source Type: news

NCCN to Host 9th Annual Congress: Hematologic Malignancies in New York, NY
The National Comprehensive Cancer Network® (NCCN®) will host its 9th Annual Congress: Hematologic Malignancies™ in New York, NY, September 19 - 20, 2014. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) will host its 9th Annual Congress: Hematologic Malignancies™ at the New York Marriott Marquis, in New York, NY, September 19 - 20, 2014. Moderated by Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, chair of the NCCN ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - August 30, 2014 Category: Cancer & Oncology Source Type: news

NCCN Offers Free Webinars for Patients with Non-Small Cell Lung Cancer
On August 16, 2014, NCCN will host the second of two free patient information webinars designed to allow patients and their caregivers the opportunity to listen to live expert discussions about non-small cell lung cancer. FORT WASHINGTON, PA - On Thursday, July 24, 2014, the National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, hosted its first of two free patient information webinars titled, "Know What Your Doctors Know: Non-Small Cell Lung Cancer... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - July 30, 2014 Category: Cancer & Oncology Source Type: news

“Roswell Park Cancer Institute Genomic Sequencing Test Wins New York State Approval,” Roswell Park Cancer Institute
The New York State Department of Health (DOH) has granted Roswell Park Cancer Institute approval to begin genomic testing of cancer patients using its OmniSeq TargetTM advanced molecular diagnostic laboratory test. Roswell Park Cancer Institute is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - July 24, 2014 Category: Cancer & Oncology Source Type: news

Top-Ranked Hospitals for Cancer – U.S. News and World Report
U.S. News and World Report has issued its list of the 50 top-ranked cancer hospitals in the United States. This list features a number of NCCN Member Institutions, including the top five: Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center Mayo Clinic Cancer Center Dana-Farber/Brigham and Women's Cancer Center The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - July 23, 2014 Category: Cancer & Oncology Source Type: news

“Huntsman Cancer Institute Receives Funding to Establish a National Clinical Trials Network Site,” Huntsman Cancer Institute at the University of Utah
A team of physician-researchers from Huntsman Cancer Institute at the University of Utah will receive nearly $3.6 million over the next five years in a cooperative agreement with the National Institutes of Health (NIH) to establish a Network Lead Academic Participating Site (NLAPS). The award places HCI in an elite group of only 30 to 40 NLAPS locations nationwide; these sites are part of the NIH effort to create a new National Clinical Trials Network (NCTN). Huntsman Cancer Institute at the ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - July 17, 2014 Category: Cancer & Oncology Source Type: news

“Prostate Cancer in Young Men – More Frequent and More Aggressive?” University of Michigan Comprehensive Cancer Center
The number of younger men diagnosed with prostate cancer has increased nearly six-fold in the last 20 years, and the disease is more likely to be aggressive in these younger men, according to a new analysis from researchers at the University of Michigan Comprehensive Cancer Center-one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - July 15, 2014 Category: Cancer & Oncology Source Type: news

“Game Theory” Model Reveals Vulnerable Moments for Metastatic Cancer Cells' Energy Production,” The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cancer's no game, but researchers at Johns Hopkins are borrowing ideas from evolutionary game theory to learn how cells cooperate within a tumor to gather energy. Their experiments, they say, could identify the ideal time to disrupt metastatic cancer cell cooperation and make a tumor more vulnerable to anti-cancer drugs. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - July 15, 2014 Category: Cancer & Oncology Source Type: news

“4 Lessons for Effective, Efficient Research in Health Care Settings,” University of Colorado Cancer Center
Thousands of studies take place every year in healthcare settings. A report published recently in the American Journal of Preventative Medicine describes how to do many of these studies more rapidly. By taking into account the real-world constraints of the systems in which providers deliver care and patients receive it, researchers can help speed results, cut costs, and increase chances that recommendations from their findings will be implemented. University of Colorado Cancer Center is one o... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - July 14, 2014 Category: Cancer & Oncology Source Type: news

NCCN to Host Policy Summit Addressing the Impact of Health Care Reform on Academic Oncology Practice
On July 10, 2014, NCCN will host the NCCN Policy Summit: The Impact of Health Care Reform on Academic Oncology Practice, at The Westin Arlington Gateway in Arlington, Virginia, as part of the NCCN Oncology Policy Program. FORT WASHINGTON, PA - On July 10, 2014, the National Comprehensive Cancer Network® (NCCN®) will host the NCCN Policy Summit: The Impact of Health Care Reform on Academic Oncology Practice, at The Westin Arlington Gateway in Arlington, Virginia, as part of the NCCN Oncolo... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - July 3, 2014 Category: Cancer & Oncology Source Type: news

“Some Aggressive Cancers May Respond to Anti-inflammatory Drugs,” Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Studying triple-negative breast cancer, researchers at the Siteman Cancer Center and Washington University School of Medicine found that some aggressive tumors rely on an antiviral pathway that appears to drive inflammation, widely recognized for roles in cancer, rheumatoid arthritis and other inflammatory diseases. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 27, 2014 Category: Cancer & Oncology Source Type: news